ANI Pharmaceuticals Competitors and Similar CompaniesClear all
Sorrento Therapeutics's competitors and similar companies include Merus.
 Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
|  Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | |
Founding Date | Founding Date 2006 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ San Diego, US | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 31019% decrease | Employees 260 |
Valuation ($) | Valuation ($) 1.5 m | Valuation ($) 3.6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $62.8m (FY, 2022) | Revenue (est.) $36.1m (FY, 2024) |
Net income | Net income ($577.8m) (FY, 2022) | Net income ($215.3m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 42.6m | Total funding raised $ 149.3m |
For sources of this data, please see the company profile
View Company Profiles
Merus
HQ
Utrecht, NL
Employees
260
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company